Birkenstock Holding (NYSE:BIRK) 주식

Birkenstock Holding

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

Kuala,Lumpur,,Malaysia,-,December,01,,2023:,Interior,Shot,Of

Analyst Color

News

Price Target

Reiteration

Analyst Ratings

General

BBWI

BIRK

BOOT

BURL

LEVI

LULU

OLLI

ROST

URBN

JP모건 애널리스트 매튜 보스(Matthew R. Boss)에 따르면, 1분기 소매업 펀더멘털은 예상에 근접한 추세를 보이고 있으며, 부활절이 있는 4월 말에 더 강력한 모멘텀이 나타날 조짐을 보이고 있다. 

JP모건 애널리스트 &#34;관세 압력 증가 시 소비자들은 할인 소매업체 찾을 것&#34;

DRI, Darden

Large Cap

Movers

Trading Ideas

CHWY

DOCS

KVYO

NBIX

TEVA

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 테바 파마수티컬스(NYSE:TEVA)의 주식은 회사와 사노피 SA(NASDAQ:SNY)가 궤양성 대장염 및 크론병에 대한 두바키투그(Duvakitug)의 2b상 시험에서 1차 평가변수가 충족되었다고 발표한 후 주가는 33.88% 상승했다.

테바, 리 오토 및 다덴 레스토랑이 지난주 최고 성과를 보여준 10개 대형주 중 일부 (12월 16-20일)

Moderna

APTV

BGNE

MRNA

POOL

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 월그린스 부츠 얼라이언스(NASDAQ:WBA)의 주가는 회사가 혼합된 3분기 실적을 보고하고 2024년 지침을 컨센서스 추정치보다 낮게 낮춘 후 24.12% 하락했다. 분석가들은 주식에 대한 가격 예측을 하향 조정했다.

모더나와 월그린스는 지난주 최악의 성과를 보인 10대 대형주 중 일부 (6월 23일-6월 29일)

Birkenstock Holding PLC

Birks Group Inc

JP Morgan analyst Tien-Tsin Huang maintains Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) with a Neutral and lowers the price target from $115 to $85.

JP Morgan Maintains Neutral on Global Payments, Lowers Price Target to $85

B&amp;G Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>) lowers FY2025 Adj EPS guidance from $0.65-$0.75 to $0.55-$0.65 vs $0.68 analyst estimate. Lowers FY2025 sales outlook from $1.89 billion-$1.95 billion to $1.86 billion-$1.91 billion vs $1.91 billion estimate.

Guidance

B&G Foods Lowers FY2025 Adj EPS Guidance from $0.65-$0.75 to $0.55-$0.65 vs $0.68 Est; Lowers FY2025 Sales Guidance from $1.89B-$1.95B to $1.86B-$1.91B vs $1.91B Est

AvidXchange Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDX#NASDAQ">AVDX</a>) shares are trading higher premarket on Wednesday. On Tuesday, the company <a href="https://www.benzinga.com/pressreleases/25/05/b45238065/corpay-invests-alongside-tpg-to-acquire-avidxchange">inked a deal to be acquired</a> by Corpay, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) and TPG Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>).
The acquisition price is set at $10 per share in cash, valuing AvidXchange at $2.2 billion, and reflects a 22% increase over AvidXchange&#8217;s closing stock <a href="https://www.benzinga.com/pressreleases/25/05/g45237804/avidxchange-agrees-to-be-acquired-by-tpg-in-partnership-with-corpay-for-2-2-billion" target="_blank" rel="noreferrer noopener">price of $8.20 on May 6, 2025</a>.
It also represents a 16% premium compared to the 90-day average trading price up to that date and a 45% premium over the $6.89 closing price on March 12, 2025, the last trading day before potential transaction reports began circulating in the media.
Also Read: <a href="https://www.benzinga.com//node/45114332">Corpay Interests Align Well With Mastercard: Analyst</a>
According to the agreement, Corpay will invest around $500 million for a 33% ownership stake in the privatized company.
The transaction is anticipated to be finalized in the fourth quarter of 2025, subject to shareholder and regulatory approvals and the fulfillment of customary closing conditions.
The company anticipates this transaction will positively impact <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">Corpay&#8217;s earnings starting in 2026</a>.
The structure of taking AvidXchange private offers Corpay the agility to implement changes and accelerate profit expansion.
Furthermore, Corpay retains the option to acquire the remaining ownership of AvidXchange in 2028.
Ron Clarke, Chairman and CEO of Corpay said, &#8220;AvidXchange has over 8,500 highly satisfied customers in complementary verticals. It has a large merchant payment network with a combination of virtual card and ACH+ acceptance.&#8221;
&#8221;Additionally, we really like AvidXchange&#8217;s business model: diverse revenue streams from payments and software, high retention rates, and very little working capital and credit exposure.&#8221;
John Flynn, Partner at TPG added, &#8220;AvidXchange is addressing this need, providing a differentiated payment network and end-to-end tools that integrate seamlessly into workflows, enabling strong connectivity between businesses and their suppliers.&#8221;
As of March 31, 2025, Corpay&#8217;s cash and cash equivalents <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">stood at $1.55 billion</a>.
Investors can gain exposure to the stock via Fidelity Disruptive Finance ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDFF#NASDAQ">FDFF</a>) and Managed Portfolio Series Tremblant Global ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOGA#NYSE">TOGA</a>).
Price Action: AVDX shares are up 18.41% at $9.71 premarket at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/25/05/45193332/ackmans-900-million-power-play-pershing-square-takes-massive-stake-in-howard-hughes-with-48-premium" target="_blank" rel="noreferrer noopener">Ackman&#8217;s $900 Million Power Play: Pershing Square Takes Massive Stake In Howard Hughes With 48% Premium</a></li>
</ul>
Photo via Shutterstock

Equities

Small Cap

AVDX

CPAY

FDFF

TOGA

AvidXchange To Go Private For 22% Premium In M&A Deal

The New Recruiting Initiative has the Potential to Bring 525 Students from these Regions into Davis University over the Term of the Agreement
EpicQuest Education Group International Limited (NASDAQ:&nbsp;EEIQ), ("EpicQuest&nbsp;Education", "EEIQ"&nbsp;or the "Company"), a provider of&nbsp;higher education&nbsp;for domestic and international students in the US, Canada and the&nbsp;UK, today announced that on May 1, 2025, its owned and operated&nbsp;Davis University&nbsp;("Davis")&nbsp;entered into an Agency Agreement (the "Agreement") with MSM Unify to drive student recruitment from Africa and the Middle East on behalf of Davis University.
Jianbo Zhang, Chief Executive Officer of EpicQuest Education, commented, "We are excited to announce our recruiting agreement with MSM Unify, a leading international student recruiter whom we believe can further add to our international students from China and India at Davis University with new students from Africa and the Middle East. We believe that this is a cost-effective strategy for Davis since MSM Unify has both the infrastructure and know how to reach students and families in these new regions."
"MSM Unify provides extensive student recruiting services such as applications, study permits and visa support which can increase conversion rates, and its data-driven recruiting can facilitate the understanding of student preferences. As Africa and the Middle East represent high-growth student populations, we are keen to develop this student recruitment pool as it will increase our student enrollment at Davis. We also believe that a more diversified student body improves a campus learning environment, enhances students' social experiences and helps all of Davis' students succeed in the global job marketplace," CEO Jianbo Zhang concluded.

Contracts

EEIQ

Epicquest Education Group Announces That Its Owned And Operated Davis University Entered Into An Agency Agreement With MSM Unify To Drive Student Recruitment From Africa And The Middle East

<figure class="wp-block-image aligncenter size-large"><img loading="lazy" decoding="async" width="1024" height="512" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1-1024x512.jpg" alt="" class="wp-image-12481" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1-1024x512.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1-300x150.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1-768x384.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07003646/1.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">A Painful Visit For Canada&#8217;s New Prime Minister</h2>
Canadian Prime Minister Mark Carney couldn&#8217;t have been encouraged by President Trump&#8217;s comments ahead of their meeting on Tuesday. As ZeroHedge reported: 
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">Update (1130ET):&nbsp;Ahead of his meeting with freshly elected Canadian PM Mark Carney, President Trump has made his feelings clear about the relationship with USA&#8217;s northern 
neighbor.
In a post on his social media platform Truth Social, President Trump
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">&#8220;I look forward to meeting the new Prime Minister of Canada, Mark Carney. I very much want to work with him, but cannot understand one simple TRUTH &#8211;&nbsp;Why is America subsidizing Canada by $200 Billion Dollars a year, in addition to giving them FREE Military Protection, and many other things?&#8221;&nbsp;
</blockquote>
Trump then went further:
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">&#8220;We don't need their Cars, we don't need their Energy, we don't need their Lumber, we don't need ANYTHING they have,&nbsp;other than their friendship, which hopefully we will always maintain.&nbsp;
They, on the other hand, need EVERYTHING from us!&nbsp;
The Prime Minister will be arriving shortly and that will be, most likely,&nbsp;my only question of consequence.
</blockquote>
</blockquote>
Things didn&#8217;t get better for Carney once he got to the White House. A reporter asked Trump if there was anything Carney could so in their meeting that would prompt Trump to lift his tariffs. Trump said no. Asked why, he said, &#8220;That&#8217;s just the way it is.&#8221;&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is the very moment Mark Carney realized he LOST everything. Just look at his body language after hearing Trump&#39;s firm response. <a href="https://t.co/wBqwKnZJ6Z">pic.twitter.com/wBqwKnZJ6Z</a>
&mdash; George (@BehizyTweets) <a href="https://twitter.com/BehizyTweets/status/1919801084765200777?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
So, once again, it looks like the Trump tariffs are set to continue.&nbsp;
<h2 class="wp-block-heading">The Trump Tariffs Continue</h2>
As we&#8217;ve mentioned before, the $64 trillion question is whether Trump's tariffs are intended to balance trade (in which case, they're sticking around) or a negotiating tactic (in which case, they'll be rolled back).
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/p/revisiting-the-64-trillion-question"><img loading="lazy" decoding="async" width="917" height="808" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004059/2.jpg" alt="" class="wp-image-12482" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004059/2.jpg 917w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004059/2-300x264.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004059/2-768x677.jpg 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
On Sunday, we got two more indications that they're meant to balance trade. The first was in<a href="https://www.wsj.com/opinion/trumps-three-steps-to-economic-growth-tariffs-trade-tax-cuts-deregulation-7804053a"> a WSJ op/ed</a> by Treasury Secretary Bessent, in which he wrote, "Tariffs are an effective tool for balancing international commerce." (counterpoint: today Bessent suggested there could be trade deals as soon as this week). The second was a new tariff announced by President Trump, a 100% tariff on foreign movies.
<figure class="wp-block-image aligncenter size-full"><img loading="lazy" decoding="async" width="588" height="373" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004229/3-Movies.jpg" alt="" class="wp-image-12483" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004229/3-Movies.jpg 588w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004229/3-Movies-300x190.jpg 300w" sizes="(max-width: 588px) 100vw, 588px" /></figure>
<h2 class="wp-block-heading">Angle On: Canada</h2>
A lot of movies shown in the U.S. are at least partially filmed in Canada. We had already bet against a Canadian trucking name last week, 
<figure class="wp-block-image aligncenter size-large"><a href="https://portfolioarmor.substack.com/p/trade-alert-trucking"><img loading="lazy" decoding="async" width="1024" height="683" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4-1024x683.jpg" alt="" class="wp-image-12484" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4-1024x683.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4-300x200.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4-768x512.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004311/4.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
So we decided research other possible Canadian stocks we could bet against. We looked for names that met these three criteria:
<ol>
<li>Have shares traded in the U.S.</li>
<li>Have options traded on those shares.</li>
<li>U.S. tariffs are likely to be materially negative for them. .</li>
</ol>
And we came up with five:
<figure class="wp-block-image aligncenter size-full"><img loading="lazy" decoding="async" width="800" height="486" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004355/5.png" alt="" class="wp-image-12485" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004355/5.png 800w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004355/5-300x182.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004355/5-768x467.png 768w" sizes="(max-width: 800px) 100vw, 800px" /></figure>
On Wednesday, we placed bearish bets on all of them. You can read the details about that&nbsp;<a href="https://portfolioarmor.substack.com/p/trade-alert-fading-canada">here</a>.&nbsp;
And if you&#8217;d like to add some downside protection here, in light of legendary hedge fund manager Paul Tudor Jones&#8217;s warning about new lows, you can download our optimal hedging app by aiming your iPhone camera at the QR code below (or by <a href="https://apps.apple.com/us/app/portfolio-armor/id394951144">tapping here</a>, if you&#8217;re reading this on your phone). Our app can help you find the least expensive hedges given your risk tolerance and time frame.
<figure class="wp-block-image size-large"><a href="https://apps.apple.com/us/app/portfolio-armor/id394951144"><img loading="lazy" decoding="async" width="1024" height="683" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG-1024x683.jpeg" alt="" class="wp-image-12486" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG-1024x683.jpeg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG-768x512.jpeg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004537/PA-JPEG.jpeg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
If you&#8217;d like to stay in touch
You can scan for optimal hedges for individual securities, find our current top ten names, and&nbsp;create hedged portfolios&nbsp;on&nbsp;<a href="https://portfolioarmor.com/">our website</a>.&nbsp;You can also follow Portfolio Armor on X&nbsp;<a href="https://twitter.com/portfolioarmor">here</a>, or become a free subscriber to our trading Substack using the link below (we&#8217;re using that for our occasional emails now).
<figure class="wp-block-image aligncenter size-full"><a href="https://portfolioarmor.substack.com/"><img loading="lazy" decoding="async" width="581" height="372" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004749/Widget.jpg" alt="" class="wp-image-12487" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004749/Widget.jpg 581w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07004749/Widget-300x192.jpg 300w" sizes="(max-width: 581px) 100vw, 581px" /></a></figure>

Options

Global

Opinion

Markets

Why We Decided To Bet Against Canada

<a href="https://data.epo.org/publication-server/publications/pdf?path=2025/19/DOC/EPNWB1/EP21191547NWB1/EP21191547NWB1.pdf" title="https://data.epo.org/publication-server/publications/pdf?path=2025/19/DOC/EPNWB1/EP21191547NWB1/EP21191547NWB1.pdf">https://data.epo.org/publication-server/publications/pdf?path=2025/19/DOC/EPNWB1/EP21191547NWB1/EP21191547NWB1.pdf</a>

Biotech

SHPH

Shuttle Pharmaceuticals Has Been Granted A European Patent Titled "DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION (FOR TREATMENT OF CANCERS, NEUROLOGICAL DISORDERS, & IMMUNOLOGICAL DISORDERS)"

JP Morgan analyst Arun Jayaram maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Overweight and lowers the price target from $49 to $47.

VNOM

JP Morgan Maintains Overweight on Viper Energy, Lowers Price Target to $47

ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) will release earnings results for the first quarter, before the <a href="https://www.benzinga.com/quote/COP/earnings">opening bell on Thursday, May 8</a>.
Analysts expect the Houston-based company to report quarterly earnings at $2.05 per share, up from $2.03 per share in the year-ago period. ConocoPhillips projects to report quarterly revenue at $15.91 billion, compared to $14.48 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 29, Bank of America Securities analyst Kalei Akamine downgraded the rating for ConocoPhillips from Buy to Neutral and lowered the price target from $138 to $107.
With the recent buzz around ConocoPhillips, some investors may be eyeing potential gains from the company's dividends. As of now, ConocoPhillips offers an annual dividend yield of 3.56% — a quarterly dividend of 78 cents per share ($3.12 a year).  
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $168,512 or around 1,923 shares. For a more modest $100 per month or $1,200 per year, you would need $33,738 or around 385 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($3.12 in this case). So, $6,000 / $3.12 = 1,923 ($500 per month), and $1,200 / $3.12 = 385 shares ($100 per month).
Note that dividend yield can change on a rolling basis; the dividend payment and the stock price fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
COP Price Action: Shares of ConocoPhillips gained 0.02% to close at $87.63 on Tuesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>
Image: Shutterstock

Earnings

Long Ideas

How To Earn $500 A Month From ConocoPhillips Stock Ahead Of Q1 Earnings

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAWN#NASDAQ">DAWN</a>) with a Buy and lowers the price target from $30 to $27.

DAWN

Needham Maintains Buy on Day One Biopharmaceutical, Lowers Price Target to $27

Greystone Housing Impact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHI#NYSE">GHI</a>) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.25 by 56 percent. This is a 73.81 percent decrease over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $25.13 million which beat the analyst consensus estimate of $24.03 million by 4.55 percent. This is a 12.31 percent increase over sales of $22.37 million the same period last year.

Earnings Beats

Earnings Misses

Greystone Housing Impact Q1 EPS $0.11 Misses $0.25 Estimate, Sales $25.13M Beat $24.03M Estimate

JP Morgan analyst Arun Jayaram maintains Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) with a Overweight and lowers the price target from $167 to $161.

FANG

JP Morgan Maintains Overweight on Diamondback Energy, Lowers Price Target to $161

Liberty Broadband (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDK#NASDAQ">LBRDK</a>) reported quarterly earnings of $1.87 per share. This is a 10.65 percent increase over earnings of $1.69 per share from the same period last year. The company reported quarterly sales of $266.00 million which beat the analyst consensus estimate of $248.60 million by 7.00 percent. This is a 8.57 percent increase over sales of $245.00 million the same period last year.

LBRDK

Liberty Broadband Q1 GAAP EPS $1.87 Up From $1.69 YoY, Sales $266.00M Beat $248.60M Estimate

Liberty Broadband (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDA#NASDAQ">LBRDA</a>) reported quarterly earnings of $1.87 per share. This is a 10.65 percent increase over earnings of $1.69 per share from the same period last year. The company reported quarterly sales of $266.00 million which beat the analyst consensus estimate of $248.60 million by 7.00 percent. This is a 8.57 percent increase over sales of $245.00 million the same period last year.

LBRDA

Liberty Broadband Q1 EPS $1.87 Up From $1.69 YoY, Sales $266.00M Beat $248.60M Estimate

Funding Supports Advancement of Obesity Program and Strategic Business Development&nbsp;Initiatives
<ul>
<li>Advancement of novel next-generation MC4R long-acting peptides and oral small molecules
<ul>
<li>IND applications planned for Q4 2025; clinical data expected H1 2026</li>
<li>Phase 1 SAD/MAD studies to include patients with hypothalamic obesity</li>
</ul>
</li>
<li>Ocular asset collaborations expected in Q2 and Q3 2025</li>
</ul>
&nbsp;Palatin Technologies, Inc. (the "Company" or "Palatin") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PTN#NYSE">PTN</a>), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced today that it expects to close its previously announced pricing of a public offering consisting of $11.5 million upfront and up to an additional $11.5 million upon the cash exercise of the milestone related warrants, on May 8, 2025. The Company believes the upfront amount of $11.5 million in gross proceeds, combined with approximately $2.3 million in net proceeds received in April 2025 under its at-the-market (ATM) facility, and its current plans and operations will be sufficient to resolve the delisting determination of NYSE American.

Palatin Announces It Expects $11.5M Financing To Remedy NYSE American Delisting Notice

"Disney Expects To Recognize Non-Cash Tax Benefit Of ~$3.3B Related To Termination Of Hulu's Partnership Tax Status In Q3"- SEC Filing

TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.46 by 4.35 percent. This is a 2.04 percent decrease over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $476.26 million which beat the analyst consensus estimate of $469.13 million by 1.52 percent. This is a 5.55 percent increase over sales of $451.21 million the same period last year.

TPG Q1 Adj. EPS $0.48 Beats $0.46 Estimate, Sales $476.26M Beat $469.13M Estimate

White Mountains Insurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTM#NYSE">WTM</a>) reported quarterly earnings of $13.19 per share. This is a 85.71 percent decrease over earnings of $92.33 per share from the same period last year. The company reported $577.80 million in sales this quarter. This is a 10.74 percent decrease over sales of $647.30 million the same period last year.

White Mountains Insurance Q1 EPS $13.19 Down From $92.33 YoY, Sales $577.80M Down From $647.30M YoY

<a href="https://www.ft.com/content/42458681-95c4-463e-866d-1c6968e61df6" title="https://www.ft.com/content/42458681-95c4-463e-866d-1c6968e61df6">https://www.ft.com/content/42458681-95c4-463e-866d-1c6968e61df6</a>

Reported Earlier: "EU Eyes Tariffs On Boeing Jets In Retaliation Plan" - Financial Times

Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.79) by 88.61 percent. This is a 94.8 percent increase over losses of $(1.73) per share from the same period last year. The company reported quarterly sales of $81.00 thousand which beat the analyst consensus estimate of $61.75 thousand by 31.17 percent. This is a 10.96 percent increase over sales of $73.00 thousand the same period last year.

CLNN

Clene Q1 EPS $(0.09) Beats $(0.79) Estimate, Sales $81.00K Beat $61.75K Estimate

B&amp;G Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.15 by 73.33 percent. This is a 77.78 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $425.40 million which missed the analyst consensus estimate of $459.53 million by 7.43 percent. This is a 10.48 percent decrease over sales of $475.22 million the same period last year.

B&G Foods Q1 Adj. EPS $0.04 Misses $0.15 Estimate, Sales $425.40M Miss $459.53M Estimate

Press Releases

Birkenstock Announces Third Quarter 2024 (Ended June 30, 2024) Results Date and Conference Call

Birkenstock Reports Record Third Quarter Revenue, up 19% Year-Over-Year, Driven by Continued Strong and Growing Consumer Demand

Events

Birkenstock Announces September Conference Participation

Birkenstock Announces Fourth Quarter and Full Fiscal Year 2024 (Ended September 30, 2024) Results Date and Conference Call

Birkenstock Reports Fiscal 2024 Results: Revenue Growth and Adjusted EBITDA Ahead of Expectations

Birkenstock Announces First Quarter 2025 (Ended December 31, 2024) Results Date and Conference Call and January Conference Participation

Management

Ivica Krolo Appointed as New Chief Financial Officer of the Birkenstock Group

Birkenstock Reports Fiscal First Quarter 2025 Results: Revenues Up 19%

Birkenstock Announces Fiscal Second Quarter 2025 (Ended March 31, 2025) Results Date and Conference Call

Comments

Birkenstock Holding

뉴스

파트너 / 기고자

벤징가 글로벌